The Platform offers comprehensive support to researchers at all stages of their projects, from initial design to scientific dissemination. It provides detailed methodological guidance, including protocol development and document management, as well as guidance on regulations and ethics. Additionally, we facilitate scientific communication by supporting manuscript preparation and grammatical correction. We are committed to expanding our services to meet the evolving needs of the scientific community

Management and operational delivery of the clinical elements within a trial including site selection, start-up, enrollment management, site engagement and support, monitoring planning and execution, regulatory documentation, data cleaning activities and close-out. Monitoring clinical trials in compliance with monitoring plans, local/international regulations, SOPs and ICH guidelines.The ISCIII Support Platform for Clinical Research, SCReN (Spanish Clinical Research Network) is a network structure that supports independent/academic clinical research. It is currently made up of 34 research units (UICs) distributed in 14 autonomous communities in charge of providing support to hospital centers throughout the SNS. The platform provides scientific-technical support and has extensive experience in managing national and international projects.

I currently work as a scientific communicator on my own. We are living at a very exciting time for science seeing how the pace of scientific discovery is moving faster than ever. Scientific research and researchers work not only to understand the world, but also to change it. I think it vital that we communicate to the public and discuss in an informed way the excitement of science, the diverse fields available in science, the economic and social importance of science and the many discoveries arising from scientific advances.

EN: I bring experience and knowledge about specific scientific contents, either personally or through professional connections and networks.I consider and recommend in biotech and biomedical areas partners and teachers either for educational programs in health, or for programs for research and innovation.ES: Aporto experiencia y conocimientos sobre contenidos científicos específicos, ya sea de forma personal o mediante conexiones y redes profesionales. Considero y recomiendo en áreas de biotecnología y biosanitaria, los partners y los docentes bien para programas educativos en salud, bien para programas para la Investigación y la Innovación.

Carry out the peer review process, it should be performed in detail and required modifications need to be suggested clearly. Suggestion of novel ideas and providing guidance to implement them is one of the significant responsibilities. Help in planning journal activities and their timely implementation. Guide the journal to enhance the aim and scope.

EN: In the area of R&D of the company we carry out a development very close to the market backed by 10 international patents thanks to an aggressive R&D program led by a brilliant scientific team.ES: En el ámbito de la I+D de la empresa llevamos a cabo un desarrollo muy cercano al mercado respaldado por 10 patentes internacionales gracias a un agresivo programa de I+D dirigido por un brillante equipo científico.

EN: Director of the R & D Department . This department is charged with developing new products, business lines, applications and techniques involving antibodies and/or recombinant proteins.ES: Dirección del Departamento de I+D. Dicho departamento se encarga del desarrollo de nuevos productos, líneas de negocio, aplicaciones y técnicas que implican anticuerpos y/o proteínas recombinantes.

EN: Research and development of new molecules with therapeutic applications in oncology and inflammatory diseases and parasitic diseases.Implementation of Pharmacological Screening Unit and Functional Pharmacogenomics Unit.ES: Investigación y desarrollo de nuevas moléculas con aplicación terapéutica en las áreas de oncología y enfermedades parasitarias e inflamatorias. Puesta en marcha de una Unidad de Screening Farmacológico y una Unidad de Farmacogenómica Funcional.

EN: Mechanisms in Metastatic Colon Cancer. We have found that Cox-2 is overexpressed in colon carcinoma, and it is induced in response to tumor agents by calcineurin/NFAT pathway. Genetic manipulation of this pathway significantly alters the growth and metastatic capacity.ES: Mecanismos metastásicos en el Cáncer de Colon. Hemos encontrado que Cox-2 está sobreexpresado en carcinoma de colon, y se induce en respuesta a agentes tumorales, por la ruta Calcineurina/NFAT. La manipulación genética de esta ruta altera significativamente el crecimiento y especialmente la capacidad metastasica

EN: Multiple Myeloma Genomics. Analysis Multiple Myeloma genomic profiles in order to discriminate groups within this disease and associate them with specific pharmacological behavior.Acute lymphoblastic leukemia Genomics (ALL). Genomic analysis of the different profiles of the ALL groups with the aim of finding specific tumor targets.Drug resistance in multiple myeloma. Analysis of genomic factors for drug resistance in Multiple Myeloma.ES: Genómica del Mieloma Múltiple. Análisis de los perfiles genómicos del Mieloma Múltiple con el objetivo de discriminar grupos dentro de esa enfermedad y asociarlos a comportamientos farmacológicos concretos.Genómica de Leucemia Linfobástica Aguda (LLA). Análisis de los ditintos perfiles genómicos de cada uno de los grupos de LLA con el objetivo de encontrar dianas tumorales específicas.Resistencia a fármacos en Mieloma Múltiple. Análisis de los factores genómicos a la resistencia farmacológica en Mieloma Múltiple.

EN: Methylation patterns in multiple myeloma and its implications in pathology.ES: Patrones de metilación en Mieloma Múltiple y sus implicaciones en su patología.